This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Juvenile polyarteritis
M13_JUVEPOLYNOD
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
5 |
4. Check minimum number of eventsNone |
5 |
5. Include endpointsNone |
5 |
6. Filter based on genotype QC (FinnGen only) |
5 |
Control definitions (FinnGen only)
- Control exclude
- M13_SYSTCONNECT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M30
- Name in latin
- Polyarteritis nodosa juvenilis
Similar endpoints
↥List of similar endpoints to
Juvenile polyarteritis
based on the number of shared cases.
Similar with more cases:
- Polyarteritis nodosa and related conditions
- Systemic connective tissue disorders
- Reimbursement for rheumatic diseases
- Autoimmune diseases related-to ILD
- Inflammatory bowel disease treatment related agents
Similar with less cases:
None
Case counts by codes
↥FinnGen case counts by registry codes:
Not enough data for upset plot.
Not enough data for upset table.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 85 | 55 | 30 |
| Only index persons | 60 | 35 | 25 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
| Median age at first event (years) | |||
| Whole population | - | 61.30 | 20.15 |
| Only index persons | 21.29 | 22.44 | 19.69 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5 | - | - |
| Unadjusted period prevalence (%) | 0.00 | - | - |
| Median age at first event (years) | 23.26 | - | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42870588) Differential panel, method unspecified - Blood
5
7
+∞
3.64
7.6
2.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
5
11
+∞
2.90
11.4
1.9
%
0.6
0.3
—
5
11
(3006504) Eosinophils/100 leukocytes in Blood
5
13
+∞
2.61
11.4
2.1
%
2.5
3.3
—
5
13
(3019069) Monocytes/100 leukocytes in Blood
5
13
+∞
2.61
11.6
2.3
%
8.0
6.9
—
5
13
(3018010) Neutrophils/100 leukocytes in Blood
5
14
+∞
2.48
8.0
2.2
%
61.5
62.9
—
5
14
(3002030) Lymphocytes/100 leukocytes in Blood
5
15
+∞
2.35
11.4
2.2
%
22.6
26.0
—
5
15
(3013707) Erythrocyte sedimentation rate by Westergren method
5
23
+∞
1.29
9.8
3.1
mm/h
15.4
8.9
—
5
23
(3037467) Urinalysis macro (dipstick) panel - Urine
5
28
+∞
1.12
10.8
3.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
5
38
+∞
0.24
24.4
6.5
ml/min/173m2
97.5
87.3
—
5
29
(40761511) CBC panel - Blood by Automated count
5
43
+∞
0.00
38.0
9.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
5
42
+∞
0.00
32.8
10.0
umol/l
70.0
78.2
—
5
42
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000492) Spirometry study
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_JUVEPOLYNOD and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have M13_JUVEPOLYNOD.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: M13_JUVEPOLYNOD – Juvenile polyarteritis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data